Oncology & Cancer
Scientists discover new way to target cancer
Scientists have discovered a new way to target cancer through manipulating a master switch responsible for cancer cell growth.
Dec 12, 2011
0
0
University of Bristol
Health
Insomnia could increase people's risk of type 2 diabetes, study finds
People who have difficulty getting to sleep or staying asleep had higher blood sugar levels than people who rarely had sleep issues, new research has found. The findings suggest insomnia could increase people's risk of type ...
Apr 7, 2022
0
130
Gerontology & Geriatrics
Simple clinical tool to diagnose spinal fractures in people with osteoporosis
Only 1 in 3 patients are diagnosed with broken bones in the back due to osteoporosis. One reason is that medical staff find it difficult to know who should have a back X-ray. To help address this important diagnostic care ...
Mar 14, 2022
0
52
Diabetes
BAME patients may be underrepresented in trials for diabetes treatment, study finds
Failure to directly and appropriately assess language proficiency when recruiting patients to randomised controlled trials (RCTs) for diabetes treatments may be leading to black and ethnic minority (BAME) patients being underrepresented ...
Sep 27, 2016
1
1
Health
Bans on gluten-free prescribing save the NHS money in the short-term but the impact on patients is unclear
Full or partial bans on GPs prescribing gluten-free (GF) foods to people with coeliac disease save the NHS money in the short-term. But the impact on patients, especially those from deprived areas, is unknown, NIHR-funded ...
Aug 2, 2018
0
111
Diseases, Conditions, Syndromes
New kidney research sheds light on harms of certain drugs
Scientists have identified an enzyme that is a "master regulator" of kidney function that if excessively suppressed, can trigger renal failure. Their findings have implications for the use of existing drugs and the development ...
Jan 24, 2019
0
334
Diseases, Conditions, Syndromes
New vaccine platform used to develop COVID-19 candidates
The University of Bristol and spin-out company Imophoron have announced they are ready to test COVID-19 vaccine candidates in a pre-clinical program.
Apr 8, 2020
0
210
Medications
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered ...
Jun 24, 2021
0
13
Other
3D Anatomy online: one step closer to the real thing?
(Medical Xpress) -- Learning anatomy online is to benefit from a new tool using the latest technology, which allows users to see real specimens in high-definition 3D.
May 16, 2011
0
0
Diabetes
Bristol scientists to study potential new way of treating diabetes
Scientists at the University of Bristol are to investigate a potential new way of treating diabetes, following funding from the British Heart Foundation (BHF).
Mar 1, 2016
0
3
